The effects of birth after 32-36 weeks of pregnancy on the lung function of children at the age of 12

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26209

Enrollment

Registered

2014-03-02

Start date

2014-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm birth (prematuriteit) Asthma (astma) Lung function (longfunctie) Exercise capacity (inspanningscapaciteit) Lung Clearance Index (LCI)

Interventions

Questionnaires (general, ISAAC, PAQ C) Ergometrie Spirometrie Lung Clearance Index

Eligibility

Inclusion criteria

Inclusion criteria: Research group - Born between 32 and 36 +6 weeks of gestation - From one of the three northern provinces (Drenthe, Groningen and Friesland) Control group - Born after 37 weeks gestation - From one of the three northern provinces (Drenthe, Groningen and Friesland)

Exclusion criteria

Exclusion criteria: Research group - Duration of pregnancy precisely determined by ultrasound - Physical inability to carry out fietsergometrietest - Birth Defects - Illness or fever at the time of measurement Control group: - Duration of pregnancy is not exactly determined by ultrasound - Physical inability to carry out fietsergometrietest - Birth Defects - Use of bronchodilators - Illness or fever at the time of measurement

Design outcomes

Primary

Measure	Time frame
Spirometrie : FVC, FEV1, FEV1/FVC, FEF25, FEF50, FEF75, PEF Ergometire : Hartfrequentie, ademhalingsfrequentie, maximalebelasting, VO2rust, maximale ademfrequentie, VT, VTmax, VEmax, ventilatoire reserve, VO2 op de anaerobe drempel (AD), VO2max, AD, AD/VO2, ΔVO2/ΔWR, respiratory exchange ratio, Borg score LCI : LCI, Scon, Salv	—

Contacts

Public ContactE.J.L.E. Vrijlandt

Pediatric Pulmonologist UMCG/Beatrix Children’s Hospital CA 43 Department of Pediatric Pulmonology and Pediatric Allergologie PO BOX 30.001

e.j.l.e.vrijlandt@umcg.nl+31 50 3612475

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)